New Filings & Updated Terms (5.3.19am)

NEW FILINGS

Company: Codiak BioSciences, Inc.
Symbol: CDAK
Description: Codiak BioSciences is harnessing exosomes—natural intercellular messengers—to pioneer a new class of biologic medicines, exosome therapeutics.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Jefferies, William Blair, Evercore ISI
Co-Manager(s): WedBush PacGrow
Filed: 4-30-19
Listed Cash Raise: $86.25m

Company: Chewy, Inc.
Symbol: CHWY
Description: Their mission is to be the most trusted and convenient online destination for pet parents everywhere.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Allen & Co., JP Morgan, Morgan Stanley (Alphabetical Order)
Filed: 4-29-19
Listed Cash Raise: $100m

Company: IDEAYA Biosciences, Inc.
Symbol: IDYA
Description: They are an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Citigroup, Jefferies
FIled: 4-26-19
Listed Cash Raise: $70m

Company: Peloton Therapeutics, Inc.
Symbol: PLTX
Description: They are a clinical stage biopharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): JP Morgan, Citigroup, Jefferies
FIled: 4-26-19
Listed Cash Raise: $115m

Company: Bicycle Therapeutics plc
Symbol: BCYC
Description: They are a clinical-stage biopharmaceutical company developing a novel class of medicines, which we refer to as Bicycles, for diseases that are underserved by existing therapeutics.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s):Goldman Sachs, Jefferies, Piper Jaffray
Co-Manager(s): Canaccord Genuity
Filed: 4-26-19
Listed Cash Raise: $86.25m

TERMS ADDED

Company: Avantor, Inc.
Symbol: AVTR
Description: They are a leading global provider of mission critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries.
Shares: TBD
Price Range: $18.00-$21.00
Trade Date: 5/17
Underwriter(s): Goldman Sachs, JP Morgan, BofA Merrill Lynch, Barclays, Jefferies
Co-Manager(s): Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Group, Citigroup, Piper Jaffray, RBC Capital, Cowen, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, Raymond James, Stephens Inc., Stifel, SunTrust Robinson Humphrey, Wells Fargo, Drexel Hamilton, PJT Partners
Terms Added: 5-3-19

Company: ConversionPoint Holdings, Inc.
Symbol: CPTI
Description: They will be a newly-combined technology company with a mission to provide a first-party data driven, end-to-end, artificial intelligence (AI)-powered e-commerce platform not previously available to small and mid-size businesses, or SMBs.
Shares: 6.15 million
Price Range: $6.00-$7.00
Trade Date: Tuesday, 5/14
Underwriter(s): Oppenheimer, GMP Securities
Terms Added: 4-30-19

Company: Axcella Health Inc.
Symbol: AXLA
Description: They are a biotechnology company pioneering the research and development of novel multifactorial interventions to support health and address dysregulated metabolism across a broad spectrum of consumers and patients who have limited options.
Shares: 3.6 million
Price Range: $20.00-$22.00
Trade Date: Thursday, 5/9
Underwriters: Goldman Sachs, JP Morgan, SVB Leerink
Terms Added: 4-30-19

Company: Sonim Technologies, Inc.
Symbol: SONM
Description: They are a leading U.S. provider of ultra-rugged mobile phones and accessories designed specifically for task workers physically engaged in their work environments, often in mission-critical roles.
Shares: 3.6 million
Price Range: $13.00-$15.00
Trade Date: Friday, 5/10
Underwriter(s): Oppenheimer, Lake Street
Co-Manager: National Securities
Terms Added: 4-30-19

Company: Postal Realty Trust, Inc.
Symbol: PSTL
Description: They are an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS.
Shares: 5 million
Price Range: $19.00-$21.00
Trade Date: Friday, 5/10
Underwriter(s): Stifel, Janney Montgomery Scott, BMO Capital, Height Capital Markets
Terms Added: 4-30-19

Company: Milestone Pharmaceuticals Inc.
Symbol: MIST
Description: They are a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications.
Shares: 5 million
Price Range: $14.00-$16.00
Trade Date: Thursday, 5/9
Underwriter(s): Jefferies, Cowen, Piper Jaffray
Terms Added: 4-29-19

Company: South Plains Financial, Inc.
Symbol: SPFI
Description: They are a bank holding company headquartered in Lubbock, Texas, and our wholly-owned subsidiary, City Bank, is one of the largest independent banks in West Texas.
Shares: 3.38 million
Price Range: $17.50-$19.50
Trade Date: Thursday, 5/9
Underwriter(s): Keefe Bruyette & Woods, Sandler O’ Neill
Terms Added: 4-29-19

Company: Cortexyme, Inc.
Symbol: CRTX
Description: They are a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat what we believe to be a key underlying cause of Alzheimer’s and other degenerative diseases.
Shares: 4.4 million
Price Range: $16.00-$18.00
Trade Date: Thursday, 5/9
Underwriter(s): BofA Merrill Lynch, Credit Suisse
Co-Manager: Canaccord Genuity, JMP Securities
Terms Added: 4-29-19

Company: Mayville Engineering Company, Inc.
Symbol: MEC
Description: MEC is a leading U.S.-based value-added manufacturing partner that provides a broad range of prototyping and tooling, production fabrication, coating, assembly and aftermarket components.
Shares: 6.25 million
Price Range: $19.00-$21.00
Trade Date: Thursday, 5/9
Underwriter(s): Baird, Citigroup, Jefferies
Co-Manager(s): UBS Investment Bank, William Blair
Terms Added: 4-29-19

Company: Applied Therapeutics, Inc.
Symbol: APLT
Description: They are a clinical-stage biopharmaceutical company developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.
Shares: 4 million
Price Range: $14.00-$16.00
Trade Date: Thursday, 5/9lzhe
Underwriter(s): Citigroup, Cowen, UBS Investment Bank
Co-Manager: Baird
Terms Added: 4-29-19

Company: NextCure, Inc.
Symbol: NXTC
Description: They are a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function.
Shares: 5 million
Price Range: $14.00-$16.00
Trade Date: Thursday, 5/9
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Piper Jaffray
Terms Added: 4-29-19

Company: Parsons Corporation
Symbol: PSN
Description: They are a leading provider of technology-driven solutions in the defense, intelligence and critical infrastructure markets.
Shares: 18.5 million
Price Range: $26.00-$28.00
Trade Date: Wednesday, 5/8
Underwriter(s): Goldman Sachs, BofA Merrill Lynch, Morgan Stanley
Co-Manager(s): Jefferies, Wells Fargo, Cowen, SunTrust Robinson, MUFG, Scotiabank
Terms Added: 4-29-19